Hector Alila is a highly accomplished professional with a wealth of experience in the biotechnology industry. He holds a Doctor of Philosophy (Ph.D.) in Physiology and Immunology from Cornell University. He is currently the President and Chief Executive Officer at Esperance Pharmaceuticals, where he oversees the development of novel cancer treatments designed to help patients around the world. Prior to his current position, he served as the Senior Vice President at Protalex, Inc, and the Vice President at Cell Pathways, Inc. Alila has been at the forefront of innovative research and development in the biotech industry, and his expertise has enabled him to spearhead the creation of cutting-edge treatments that have the potential to change the lives of millions.